Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis.
Reglan: No Prescription Us Pharmacy
Do coping styles mediate the relationship between disability status and psychosocial loss in people with relapsing remitting multiple sclerosis?
Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous.
GABAergic Agonists Modulate the Glutamate Release from Frontal Cortex Synaptosomes of Rats with Experimental Autoimmune Encephalomyelitis.
Contribution of pannexin1 to experimental autoimmune encephalomyelitis.
Multitasking in Multiple Sclerosis: Can it Inform Vocational Functioning?
Single-Institution Retrospective Series of Gamma Knife Radiosurgery in the Treatment of Multiple Sclerosis-Related Trigeminal Neuralgia: Factors that Predict Efficacy.
Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study.
White matter disease: Early treatment of inflammatory demyelinating disease.
Multiple Sclerosis: Association with the Interleukin-1Gene family Polymorphisms in the Turkish Population.
Latency of multifocal Visual Evoked Potentials in non-optic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions.
You're the flight surgeon: multiple sclerosis.
The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Commentary.
Neurological disorders and inflammatory bowel diseases.
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
Emerging stem cell therapies: treatment, safety, and biology.
Sarcoidosis with neurological involvement imitating multiple sclerosis: The importance of thoracic imaging.
Hepatitis B virus (HBV) infection and multiple sclerosis: One more reason to undergo vaccination?
Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis.
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Autonomic Dysregulation in Multiple Sclerosis.
Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor.
Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis.
Pages
« first
‹ previous
…
535
536
537
538
539
540
541
542
543
…
next ›
last »